Release Date: 06/05/15 16:24 Summary: Completion of Enzumo Acquisition and Listing Reinstatement Price Sensitive: Yes Download Document 885.35KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status